Institutional Manager · CIK 0001536054
Crestline Management, LP
FORT WORTH, TX · File #028-14917
Latest AUM
$53.3M
Positions
3
Top-10 Concentration
100.0%
Filings
9
Portfolio Value Over Time
2024-03
2024-06
2024-09
2024-12
2025-03
2025-06
2025-09
2025-12
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| REDUCE | DENALI THERAPEUTICS INC | DNLI | -600,000 | -$9.9M | +$6.8M |
| REDUCE | SANA BIOTECHNOLOGY INC | SANA | -600,000 | -$2.4M | +$946,888 |
| REDUCE | 8X8 INC NEW | 282914100 | 0 | $0 | -$148,627 |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 20253 pos · $53.3M
- 13F COMBINATION REPORTQ/E Sep 20253 pos · $58.1M
- 13F COMBINATION REPORTQ/E Jun 20253 pos · $62.6M
- 13F COMBINATION REPORTQ/E Mar 20253 pos · $63.2M
- 13F COMBINATION REPORTQ/E Dec 2024705 pos · $3.01B
- 13F COMBINATION REPORTQ/E Sep 2024514 pos · $1.92B
- 13F COMBINATION REPORTQ/E Jun 2024159 pos · $1.28B
- 13F COMBINATION REPORTQ/E Mar 2024157 pos · $1.13B
- 13F COMBINATION REPORTQ/E Dec 2023143 pos · $858.4M
Top 3 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | DENALI THERAPEUTICS INC | DNLI | 2,810,732 | $46.4M | 87.02% |
| 2 | SANA BIOTECHNOLOGY INC | SANA | 1,220,937 | $5.0M | 9.32% |
| 3 | 8X8 INC NEW | 282914100 | 990,580 | $2.0M | 3.66% |